Target intelligence / Profile preview

Dynamin 1 pseudogene 31 (DNM1P31)

Target
DNM1P31
Molecular classification
Other (pseudogene)
01

Overview

Dynamin 1 pseudogene 31 (DNM1P31; also known as DNM1DN4-2) is a predicted pseudogene in the human genome, related to the protein-coding gene DNM1 (Dynamin 1). DNM1P31 is not expressed as a functional protein and does not participate in biological processes such as signal transduction, endocytosis, or vesicle trafficking. Its presence is a result of evolutionary duplication events[2]. The functional gene DNM1 encodes a GTPase involved in membrane fission events and is relevant to neurological diseases and some cancer types[1][3][5], but DNM1P31 itself has no direct biological or pharmacological role. Summary of issues: - DNM1P31 is a pseudogene: It does not produce a functional protein and is not a therapeutic target[2]. - Not classified as a molecular target: It lacks drug, biomarker, and safety data. - Confusion risk: Scientific literature and drug development focus on *dynamin 1* (DNM1), not DNM1P31. For drug discovery or therapeutic targeting, you should refer to the canonical protein-coding gene **Dynamin 1** (*DNM1*), not **Dynamin 1 pseudogene 31** (*DNM1P31*)[1][2][5].

Other names
Dynamin 1 pseudogene 31DNM1DN4-2

Beyond the preview

Go deeper on Dynamin 1 pseudogene 31 (DNM1P31).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dynamin 1 pseudogene 31 (DNM1P31).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call